Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Macular Degeneration

An AI Drug Company Named a Candidate for Dry Macular Degeneration, and the Target Is Undisclosed

Insilico Medicine nominated ISM9077 for dry AMD and other eye diseases. What a preclinical candidate designation means and what remains undisclosed.

Medical Daily

FDA Approves the First Eye-Specific Bevacizumab for Wet Macular Degeneration After Two Decades of Off-Label Use

FDA approved Lytenava, the first ophthalmic bevacizumab for wet AMD. What it changes for patients who already get compounded Avastin.

Medical Daily

An Eye Drug Used Off-Label for Two Decades Now Has Formal Approval for Wet Macular Degeneration

The FDA approved the first ophthalmic bevacizumab for wet AMD on July 24. What the end of two decades of off-label use means for patients.

Medical Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Scientists Discovered How Babies Develop Sharp Central Vision Before Birth, and Vitamin A Plays a Bigger Role Than Anyone Knew

Johns Hopkins researchers found blue cone cells transform into red and green cones via Vitamin A and thyroid hormones during fetal development, overturning how scientists understood sharp vision.

Medical Daily

6 Nutrients Your Eyes Need for Better Vision That Most Indians Are Missing From Their Diet

Lutein: The filter your retina is running low onLutein is a carotenoid that deposits directly into the macula, the central part of the retina responsible for sharp, detailed vision. It acts as a biological filter against blue light and oxidative stress. The average Indian diet delivers roughly 1 to 2…

Times Life

Our eyes age too: Here’s how to reduce the risks of four common eye conditions

As an optometrist, I see how aging affects my patients every day. Their eyes are no exception. Losing their vision, and consequently, their independence, is one of the greatest fears older people have. Those who lose their vision are severely affected by it psychologically.

The Conversation

Innovative Drug Update | Kexing Biopharm Enrolls First Subject in China-based Phase I Clinical Trial of Ophthalmic Innovative Drug GB10

SHENZHEN, China, June 4, 2026 /PRNewswire/ -- Recently, the first subject was enrolled and dosed in the Phase I clinical trial in China for GB10 Injection, an innovative ophthalmic drug independently developed by Shenzhen Kexing Pharmaceutical Co., Ltd. ("Shenzhen Kexing"), a wholly-owned subsidiary of Kexing Biopharm. Designed to treat neovascular…

AAP

Read news from The Economist, FT, and more,
with one subscription

EyePoint Pharmaceuticals Eyes Transformative 2026 as DURAVYU Phase 3 Data Nears

Eyepoint Pharmaceuticals (NASDAQ:EYPT) executives said the company remains on track to report top-line data from its Phase 3 wet age-related macular degeneration program for DURAVYU, also known as EYP-1901, beginning in August, with a second pivotal trial expected to follow about two months later.

MarketBeat

How looking through static can help people with a common degenerative disease see better

The Conversation

4D Molecular Therapeutics Touts Rapid Phase 3 Momentum for Retinal Gene Therapy

4D Molecular Therapeutics (NASDAQ:FDMT) executives said the company is seeing strong clinical trial momentum for its lead retinal gene therapy candidate, 4D-150, as it advances through late-stage development for wet age-related macular degeneration and prepares to begin a Phase 3 trial in diabetic m

MarketBeat

Simple Fatty Acid Injection Reverses Age-Related Vision Loss in Mice and May Help Prevent Macular Degeneration

Discover how experimental fatty acid therapy targeting retinal lipids may help preserve vision and lower macular degeneration risk, based on new age-related eye research in mice.

Medical Daily

AREDS2 Eye Vitamins and Lifestyle Changes for Macular Degeneration Prevention and AMD Prevention

Learn how AREDS2 supplements and lifestyle habits support Macular Degeneration Prevention, AMD prevention, retinal health, and protection against central vision loss with clear, research-informed guidance.

Medical Daily

5 Canned Goods Now Being Linked To Vision Loss

Canned foods are a pantry staple—affordable, convenient, and long-lasting. But recent studies are raising red flags about how some of these items may be quietly harming your eyesight. Experts are now linking certain canned goods to increased risks of vision problems, including age-related macular degeneration (AMD) and cataracts. The culprits?…

Grocery Coupon Guide

What is Age-Related Macular Degeneration and Why Does Dame Judi Dench Have It?

Award-winning actress Judi Dench opens about about her 'crushing' loss of vision journey.

International Business Times UK

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Ocular Therapeutix Stock Skyrockets On Faster FDA Path For Vision Drug

Ocular Therapeutix Inc. (NASDAQ:OCUL) stock surged on Monday after the company announced plans to accelerate the timeline for submitting a New Drug Application (NDA) for Axpaxli (OTX-TKI) in the treatment of wet age-related macular degeneration (wet AMD).

The Independent UK

Here’s what to know about age-related macular degeneration (AMD)

Evening Standard

Dame Judi Dench fears she 'will lose the plot' due to deteriorating eyesight as she reflects on turning 91

The legendary star of screen and stage was diagnosed with age-related macular degeneration (AMD) in 2012

BANG Premier

Dame Judi Dench 'can’t recognise anybody now' as sight deteriorates

Dame Judi Dench has revealed she "can’t recognise anybody now" as her sight continues to deteriorate due to an eye condition called macular degeneration.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

This Undervalued Biotech Might Have Just Proven Its Star Drug's Staying Power

On Wednesday, Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) announced data from a post hoc analysis of the GALE extension study following five years of continuous treatment with Syfovre (pegcetacoplan injection) for geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

LiveScience

New eye implants combined with augmented-reality glasses help blind people read again in small trial

Of the 38 patients with age-related macular degeneration, 80% were able to read again after having the eye implant and using the glasses.

The Independent UK

Woman who lost vision can read again after ‘life-changing’ clinical trial

Sheila Irvine was one of 38 patients to be included in the world-first study

The Guardian - UK

Experts hail ‘remarkable’ success of electronic implant in restoring sight

Sight of 84% of people with form of age-related macular degeneration restored after being fitted with device

The Independent UK

What is Prima? The device helping those with vision loss to read again

The pioneering electronic eye implant is just 2mm by 2mm and has half the thickness of a human hair

Evening Standard

Drinking this type of coffee increases the chance of developing incurable blindness

Researchers have drawn a connection between a type of coffee and an increased likelihood of age-related macular degeneration

Woman & Home

'I don’t know how far I am from not being able to see at all' - Judi Dench opens up on her sight loss and says her 'hearing is going too'

Judi has been dealing with age-related macular degeneration for years

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Johns Hopkins University

Moorfields Eye Hospital

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.